JP Morgan Private Wealth Advisors’s Ironwood Pharmaceuticals IRWD Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-19,613	Closed	-$219K	–	1918
2021 Q1	$219K	Sell	19,613 -4,289	-18%	-$45.3K	﹤0.01%	1647
2020 Q4	$272K	Buy	23,902 +289	+1%	+$3.16K	﹤0.01%	1538
2020 Q3	$212K	Hold	23,613	–	–	﹤0.01%	1503
2020 Q2	$244K	Hold	23,613	–	–	﹤0.01%	1392
2020 Q1	$238K	Sell	23,613 -4,000	-14%	-$47K	﹤0.01%	1226
2019 Q4	$368K	Sell	27,613 -9,037	-25%	-$99.6K	﹤0.01%	1155
2019 Q3	$315K	Buy	36,650 +131	+0.4%	+$1.27K	﹤0.01%	1170
2019 Q2	$400K	Sell	36,519 -7,085	-16%	-$79.4K	﹤0.01%	1056
2019 Q1	$494K	Sell	43,604 -173,766	-80%	-$1.94M	﹤0.01%	1043
2018 Q4	$1.89M	Hold	217,370	–	–	0.01%	584
2018 Q3	$3.36M	Sell	217,370 -5,970	-3%	-$94.4K	0.02%	513
2018 Q2	$3.58M	Buy	223,340 +193,421	+646%	+$2.86M	0.02%	469
2018 Q1	$387K	Sell	29,919 -11,940	-29%	-$149K	﹤0.01%	955
2017 Q4	$526K	Buy	+41,859	New	+$547K	﹤0.01%	852

Other funds holding IRWD

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

JP Morgan Private Wealth Advisors's IRWD Position: Q2 2021 in Review

JP Morgan Private Wealth Advisors sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2021, closing a stake of 19,613 shares — an estimated $219K sold.

JP Morgan Private Wealth Advisors first reported a position in IRWD in Q4 2017 and held it in 14 quarters. The position peaked at $3.58M in Q2 2018. 208 funds tracked by Wall St. Rank hold IRWD as of Q2 2021.

JP Morgan Private Wealth Advisors reported no remaining Ironwood Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
JP Morgan Private Wealth Advisors sold 19,613 Ironwood Pharmaceuticals shares in Q2 2021, an estimated $219K.
JP Morgan Private Wealth Advisors first reported a position in Ironwood Pharmaceuticals in Q4 2017 and held it in 14 quarters.
JP Morgan Private Wealth Advisors's Ironwood Pharmaceuticals position peaked at $3.58M in Q2 2018.
208 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2021.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.